Series A startup

Who invested in Inipharm

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$35Mraised across 1 round since 2020, from 1 source

Latest round
Series A, $35MNov 2020
Investors
1
See who backed them

The rounds

  1. Nov 2020
    Series A$35M

    Source recorded

Founders and team

From Inipharm's own website: 1 on the team.

  • Katelyn PatersonSenior Director, Clinical Operations

Everyone who backed them

5AM VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Inipharm as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Frazier Life SciencesVC firmPer its own site

Quick answers about Inipharm

Who invested in Inipharm?

Inipharm's investors include 5AM Ventures.

How much has Inipharm raised?

Inipharm has raised $35M across 1 round since 2020.

When did Inipharm last raise?

Inipharm's most recent round was a Series A of $35M in Nov 2020.

What was Inipharm's biggest round?

Its most recent round, $35M in Nov 2020, is also its largest on record.

Who backed Inipharm first?

Inipharm's first round on record, in Nov 2020, was backed by 5AM Ventures.

What stage is Inipharm at?

Inipharm's latest named round is a Series A, in Nov 2020.

Companies like Inipharm

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.